Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraoperative vs Postoperative Antibiotics in Rhinoplasty
NCT04194216Phase 3Enrolling by invitation
- Sponsor
- Stanford University
- Start
- May 2020
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of cefalexin and clindamycin in surgical site infection (SSI) (2 arms), sponsored by Stanford University. Primary endpoint: Postoperative Infection Rate at 7 days. Started May 2020; status: enrolling by invitation.
02
Drugs
cefalexinclindamycin
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT04194216.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04194216.